In another clinical study on multiple sclerosis (MS) patients, 4 weeks of Crocin treatment induced a significant reduction in the levels of important pathogenic factors in MS, including lipid peroxidation, DNA damage, serum TNF-α, and IL-17 levels.58 The gene discussed is IL17A; the disease is myeloid sarcoma.